<unk> , sold under the brand name Zegalogue, is a medication used to treat severe hypoglycemia in people with diabetes. The most common side effects include nausea, vomiting, headache, diarrhea, and injection site pain.<unk>  was approved for medical use in the United States in March 2021. It was designated an orphan drug in August 2017.
Dasiglucagon
Proglucagon
Insulin degludec
Insulin aspart
Insulin detemir
Lente insulin
Ultralente insulin
Insulin glulisine